UBS Group’s Cadrenal Therapeutics CVKD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93K | Sell |
326
-8,119
| -96% | -$97.8K | ﹤0.01% | 7985 |
|
|
2025
Q1 | $149K | Buy |
8,445
+6,273
| +289% | +$111K | ﹤0.01% | 5496 |
|
|
2024
Q4 | $31.5K | Buy |
+2,172
| New | +$31.5K | ﹤0.01% | 6344 |
|
|
2023
Q4 | – | Sell |
-9
| Closed | -$92 | – | 8136 |
|
|
2023
Q3 | $92 | Buy |
+9
| New | +$92 | ﹤0.01% | 7759 |
|
|
2023
Q2 | – | Sell |
-15
| Closed | -$324 | – | 7673 |
|
|
2023
Q1 | $324 | Buy |
+15
| New | +$324 | ﹤0.01% | 7972 |
|